What is the Monoclonal Antibodies Market CAGR During the Forecast Period 2023-2032?

The Global Monoclonal Antibodies Market size is growing at a CAGR of 11.80% during the forecast period from 2023 to 2032.

What is the Monoclonal Antibodies Market Size in the Year 2022?

The Global Monoclonal Antibodies Market size was USD 198.2 Billion in 2022, growing at a CAGR of 11.80% during the forecast period from 2023 to 2032.

What is the Monoclonal Antibodies Market size During the Forecast Period?

The Global Monoclonal Antibodies Market size is expected to be worth around USD 588.0 Billion by 2032, growing at a CAGR of 11.80% during the forecast period from 2023 to 2032.

Global Monoclonal Antibodies Market By Source Type (Murine, Humanized, Chimeric, Human), By Disease Indication (Cancer, Infectious Disease, Inflammatory Disease, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Oct 2023
Report ID: 16123
Number of Pages: 286
Format:

- Novartis AG Company Profile
- Pfizer Inc Company Profile
- GlaxoSmithKline plc
- Sanofi S.A.
- Mylan N.V
- Zydus Cadila
- Lupin Ltd Company Profile
- Biogen Inc.
- Hoffman-La Roche Ltd.
- Bristol Myers Squibb Company Profile
- Merck KAGA
- Viatris Inc.
- Eli Lilly and Company
- Amgen Inc.
- Johnson & Johnson
- Merck & Co, Inc.
- AbbVie Inc. Company Profile
- Regeneron Pharmaceuticals Inc.
- Other Key Players

Related Reports

Our Clients

Report ID 16123
Published Date Oct 2023
Rating
- ★★★★★
  
  ★★★★★
- (42)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible